Spartan capital securities, llc serves as sole placement agent in lipella pharmaceuticals inc.'s $1.72 million private placement

New york, ny, dec. 18, 2024 (globe newswire) -- spartan capital securities llc, a premier investment banking firm, is pleased to announce the successful completion of a private placement for lipella pharmaceuticals inc.'s (nasdaq: lipo)  spartan capital securities, llc acted as the sole placement agent in the private offer and sale of up to 6,000,000 of series b non-voting convertible preferred stock of lipella pharmaceuticals inc. lipella pharmaceuticals inc., a clinical-stage biopharmaceutical company, successfully raised $1,722,000 through this private placement.
LIPO Ratings Summary
LIPO Quant Ranking